Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1479-5876

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer ; volume:21 ; number:1 ; day:10 ; month:2 ; year:2023 ; pages:1-22 ; date:12.2023
Journal of translational medicine ; 21, Heft 1 (10.2.2023), 1-22, 12.2023

Creator: Ganji, Mahmoud
Bakhshi, Shohreh
Shoari, Alireza
Ahangari Cohan, Reza

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12967-023-03955-5

URN: urn:nbn:de:101:1-2023041421052956403052

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:02 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Ganji, Mahmoud
Bakhshi, Shohreh
Shoari, Alireza
Ahangari Cohan, Reza
SpringerLink (Online service)

Other Objects (12)

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking

Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors

Lead generation of UPPS inhibitors targeting MRSA: Using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamic simulations

Combining docking with pharmacophore filtering for improved virtual screening

Building shape-focused pharmacophore models for effective docking screening

QSAR and molecular docking for the search of AOX inhibitors: a rational drug discovery approach

3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum

The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies

Hochschulschrift

Semiempirical MO-methods for QSAR and docking studies

Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies

Quantitative Structure‐activity Relationship (QSAR) Models for Docking Score Correction

Reverse pharmacophore mapping and molecular docking studies for discovery of GTPase HRas as promising drug target for bis-pyrimidine derivatives

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking

Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors

Lead generation of UPPS inhibitors targeting MRSA: Using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamic simulations

Combining docking with pharmacophore filtering for improved virtual screening

Building shape-focused pharmacophore models for effective docking screening

QSAR and molecular docking for the search of AOX inhibitors: a rational drug discovery approach

3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum

The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies

Hochschulschrift

Semiempirical MO-methods for QSAR and docking studies

Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies

Quantitative Structure‐activity Relationship (QSAR) Models for Docking Score Correction

Reverse pharmacophore mapping and molecular docking studies for discovery of GTPase HRas as promising drug target for bis-pyrimidine derivatives

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking

Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors

Lead generation of UPPS inhibitors targeting MRSA: Using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamic simulations

Combining docking with pharmacophore filtering for improved virtual screening

Building shape-focused pharmacophore models for effective docking screening

QSAR and molecular docking for the search of AOX inhibitors: a rational drug discovery approach

3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum

The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies

Hochschulschrift

Semiempirical MO-methods for QSAR and docking studies

Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies

Quantitative Structure‐activity Relationship (QSAR) Models for Docking Score Correction

Reverse pharmacophore mapping and molecular docking studies for discovery of GTPase HRas as promising drug target for bis-pyrimidine derivatives

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking

Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors

Lead generation of UPPS inhibitors targeting MRSA: Using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamic simulations

Combining docking with pharmacophore filtering for improved virtual screening

Building shape-focused pharmacophore models for effective docking screening

QSAR and molecular docking for the search of AOX inhibitors: a rational drug discovery approach

3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum

The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies

Semiempirical MO-methods for QSAR and docking studies

Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies

Quantitative Structure‐activity Relationship (QSAR) Models for Docking Score Correction

Reverse pharmacophore mapping and molecular docking studies for discovery of GTPase HRas as promising drug target for bis-pyrimidine derivatives

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking

Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors

Lead generation of UPPS inhibitors targeting MRSA: Using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamic simulations

Combining docking with pharmacophore filtering for improved virtual screening

Building shape-focused pharmacophore models for effective docking screening

QSAR and molecular docking for the search of AOX inhibitors: a rational drug discovery approach

3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum

The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies

Semiempirical MO-methods for QSAR and docking studies

Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies

Quantitative Structure‐activity Relationship (QSAR) Models for Docking Score Correction

Reverse pharmacophore mapping and molecular docking studies for discovery of GTPase HRas as promising drug target for bis-pyrimidine derivatives

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking

Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors

Lead generation of UPPS inhibitors targeting MRSA: Using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamic simulations

Combining docking with pharmacophore filtering for improved virtual screening

Building shape-focused pharmacophore models for effective docking screening

QSAR and molecular docking for the search of AOX inhibitors: a rational drug discovery approach

3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum

The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies

Semiempirical MO-methods for QSAR and docking studies

Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies

Quantitative Structure‐activity Relationship (QSAR) Models for Docking Score Correction

Reverse pharmacophore mapping and molecular docking studies for discovery of GTPase HRas as promising drug target for bis-pyrimidine derivatives

Related objects

Reset password